Filgrastim biosimilar (Hangzhou Jiuyuan Gene Engineering)

非格司亭生物类似药（杭州九源基因工程）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameFilgrastim biosimilar (Hangzhou Jiuyuan Gene Engineering)
Drug Alias NameFilgrastim follow-on biologic(Hangzhou Jiuyuan Gene Engineering)非格司亭生物仿制药（杭州九源基因工程）重组人粒细胞刺激因子（杭州九源基因工程）Recombinant human granulocyte colony stimulating factor(Hangzhou Jiuyuan Gene Engineering)rhG-CSF(Hangzhou Jiuyuan Gene Engineering) +[7] 
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionColony stimulating factor 3 receptor agonists
TargetsColony stimulating factor 3 receptor
Therapy Area/IndicationsNeutropenia
Global Approved IndicationsNeutropenia
Approved Indications in ChinaNeutropenia
Original Approved Country/TerritoryMainland China
Original Approved Date1998/04/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesHangzhou Jiuyuan Gene Biomedical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHangzhou Jiuyuan Gene Biomedical Co Ltd
Inactive CompaniesN/A
Active IndicationsNeutropenia
Inactive IndicationsN/A

Other Information

ATC CodeL03AA02
Related LinksN/A